OFIX

Orthofix Medical Inc. Common Stock (DE) (OFIX)

Stock · NASDAQ · Health Care

$9.4as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 13, 2026

Orthofix pays $24M in damages to former executives. Orthofix Medical has paid $24 million in damages to former executives. This significant cash outflow may impact the company's financial position. The stock currently trades near its 52-week low, with analysts averaging a $13 target price.

Active signals

Support level
$9.17
Industry
Medical/Dental Instruments

What OFIX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike36+1.6%58%
Bollinger Band Breakout20-0.0%50%
Bollinger Band Breakdown20-6.2%45%
200-Day Moving Average TouchActive now16-4.5%38%
Any 20-session window (baseline)-1.6%45%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About OFIX

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; design…

Sector
Health Care
Industry
Medical/Dental Instruments
Employees
1,605

Fundamentals

1-day range
$9.35$9.72
Market cap
$428.47M
P/E (trailing)
—
P/E (forward)
25.92
EPS (trailing)
$-1.53
Dividend yield
—
Beta
0.66
Avg. volume
377.2K
52-week range
$8.5$16.99
Next earnings: November 3, 2026 · EPS estimate $0.11confirmed

How Orthofix Medical Inc. Common Stock (DE) Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$822.31MSG&A$554.33M (67%)Cost of Revenue$256.30M (31%)R&D$65.85M (8%)Tax$1.38M (0%)OFIX

Source: 10-K filed Feb 24, 2026 · via SEC EDGAR / Finnhub

Gross Profit$566.02M(69%)
Operating Income-$81.43M(-10%)

Forecasts

4 analyst ratings

Buy 73%
Hold 27%
Sell 0%
1-year price forecast
High
$14
+48.9%
Median
$13
+38.3%
Low
$12
+27.7%

Orthofix Medical Inc. Common Stock (DE) Competitors

Chosen by industry and closest market cap.

  • OFIX
    Orthofix Medical Inc. Common Stock (DE)
    $9.38
    ▼ 2.19%
    Market cap $428.47MP/E —
    $8.5$16.99
  • MOBI
    Mobia Medical Inc. Common Stock
    $8.09
    ▼ 2.65%
    Market cap $409.63MP/E —
    $8.16$15.29
  • CLPT
    ClearPoint Neuro Inc. Common Stock
    $9.07
    ▼ 5.91%
    Market cap $408.45MP/E —
    $8.27$28.1
  • SI
    Shoulder Innovations Inc. Common Stock
    $18.09
    ▼ 1.52%
    Market cap $465.16MP/E —
    $10.92$24.6
  • CERS
    Cerus Corporation Common Stock
    $2.18
    ▼ 3.54%
    Market cap $467.54MP/E —
    $1.38$3.47
  • SGHT
    Sight Sciences Inc. Common Stock
    $8.28
    ▼ 5.91%
    Market cap $385.77MP/E —
    $3.34$9.71
  • NPCE
    Neuropace Inc. Common Stock
    $12.24
    ▼ 4.23%
    Market cap $473.90MP/E —
    $9.22$19.6

P/E shows — for peers not currently carrying a live signal of their own.

Insider Activity

Insider Actions →
Acquired
740.1K
Disposed
5.3K

Institutional Ownership

March 31, 2026

Total shares held
35.19M
Total value held
$394.72M
Institutional holders
140
Top holders this quarter
  • Unknown4.39M
  • Unknown3.98M
  • Unknown3.72M
  • Unknown3.30M
  • Unknown3.21M
  • Unknown2.70M
  • Unknown1.66M
  • Unknown1.07M
  • Unknown938.9K
  • Unknown907.4K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.